SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNUM.L Regulatory News (NUM)

  • There is currently no data for NUM

Trading Update

6 Jul 2022 07:00

RNS Number : 4196R
Numis Corporation PLC
06 July 2022
 

6 July 2022

Numis Corporation Plc ("Numis")

Trading Update

Stronger performance in Q3

 

Numis, the international investment bank, today issues a trading update in respect of the three-month period ended 30 June 2022.

Key highlights:

· Q3 revenue was in excess of £40m, which is ahead of the first half run-rate and reflects a strong improvement on the Q2 revenue performance 

· A favourable M&A environment has driven performance in investment banking and into H2, the M&A pipeline of both announced and possible transactions remains strong; equities and equity capital markets (ECM) continue to be affected by macro-themes

· European license granted, enabling greater interaction with EU-based institutional investors through Dublin office and facilitating future participation in EU ECM transactions

· While equity market and capital raising conditions continue to be challenging, the outlook remains in-line with market expectations for the full year

Favourable M&A environment drives performance in investment banking

The diversification of our investment banking activities continues to both enhance the resilience of the business and generate growth opportunities. 

Investment banking revenues have benefitted from a favourable M&A environment, which has led to increased bid activity across our corporate client base. Our strategic focus on strengthening our M&A capabilities and securing better roles and fees in these situations has continued to deliver positive results, and the outlook for M&A revenues remains encouraging.

In contrast, capital markets volumes remain subdued and whilst we have seen some recovery in activity during the third quarter, we expect macro-economic concerns to restrict deal volumes in the short term.

Equities continues to be affected by macro-themes

Equities revenues were marginally below the first half run-rate reflecting the cautious investor sentiment and market declines in the period, particularly across UK small and mid-caps. Despite these more difficult market conditions, our trading performance in Q3 was marginally better than the run rate of H1, helping to offset a quieter period for commissions. 

Dublin office to open in Q4

Our Dublin office has now received regulatory approval from the Central Bank of Ireland and we expect to commence trading during the final quarter. This will see us expand our capital markets reach to non-UK issuers; expand our leading equities platform to European institutional investors looking to gain exposure to UK equities; and further capitalise on working with high-growth private companies looking for growth capital.

Outlook - in-line with market expectations for the full year

Market conditions for equity markets and capital raising will likely remain challenging throughout the final quarter, however the M&A pipeline of both announced and possible transactions remains strong, and overall we continue to perform in line with market expectations for the full year.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

 

Contacts:

Numis Corporation:

Noreen Biddle Shah, Head of Corporate Communications 020 7260 1441

 

FTI Consulting LLP:

Edward Bridges 07768 216607

Daisy Hall 07807 298568

Grant Thornton UK LLP (Nominated Adviser): Philip Secrett 020 7728 2578Harrison Clarke 020 7184 4384

 

Notes for Editors

Numis is a leading independent investment banking group offering a full range of research, execution,

corporate broking and advisory services to companies and their investors. Numis is listed on AIM, and

has offices in London, New York and Dublin.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUVVVRUUUBRAR
Date   Source Headline
28th Mar 20223:59 pmRNSTransaction in Own Shares & Total Voting Rights
24th Mar 20223:48 pmRNSTransaction in Own Shares & Total Voting Rights
22nd Mar 20224:09 pmRNSTransaction in Own Shares & Total Voting Rights
18th Mar 20223:43 pmRNSTransaction in Own Shares & Total Voting Rights
18th Mar 202210:18 amRNSNotification of Major Holdings
17th Mar 20229:31 amRNSTransaction in Own Shares & Total Voting Rights
11th Mar 20223:36 pmRNSTransaction in Own Shares & Total Voting Rights
7th Mar 20224:47 pmRNSTransaction in Own Shares & Total Voting Rights
28th Feb 20225:02 pmRNSTransaction in Own Shares & Total Voting Rights
24th Feb 20227:00 amRNSBoard Change – Appointment of Independent NED
22nd Feb 20222:35 pmRNSTransaction in Own Shares & Total Voting Rights
10th Feb 202210:03 amRNSTransaction in Own Shares and Total Voting Rights
8th Feb 20221:13 pmRNSBoard Change
8th Feb 20221:12 pmRNS2022 Annual General Meeting ('AGM')
8th Feb 20227:00 amRNSAGM Trading Statement
7th Feb 20229:39 amRNSTransaction in Own Shares and Total Voting Rights
4th Feb 20224:14 pmRNSHolding(s) in Company
1st Feb 20224:38 pmRNSTransaction in Own Shares and Total Voting Rights
21st Jan 20224:00 pmRNSTransaction in Own Shares and Total Voting Rights
21st Jan 20221:00 pmRNSDirectors’ Dealing
19th Jan 20227:00 amRNSGrant of awards under 2021 LTIP
14th Jan 20223:53 pmRNSTransaction in Own Shares and Total Voting Rights
10th Jan 20224:27 pmRNSTransaction in Own Shares and Total Voting RIghts
5th Jan 20227:00 amRNSAppointment of General Counsel & Company Secretary
4th Jan 20223:21 pmRNSTransaction in Own Shares and Total Voting Rights
23rd Dec 20214:53 pmRNSTransaction in Own Shares and Total Voting Rights
22nd Dec 20214:33 pmRNSTransaction in Own Shares and Total Voting Rights
21st Dec 20215:04 pmRNSTransaction in Own Shares and Total Voting Rights
20th Dec 20212:30 pmRNSAnnual Report and AGM Notice
20th Dec 202112:29 pmRNSReplacement Director's Dealing
20th Dec 202112:09 pmRNSHolding(s) in Company
17th Dec 202112:31 pmRNSDirector’s Dealing
15th Dec 20217:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Dec 20217:00 amRNSFull Year Results for the year ended 30 Sep 2021
29th Nov 20214:58 pmRNSNotice of Final Results for the year ended 30 Sep
18th Nov 20214:03 pmRNSHolding(s) in Company
30th Sep 202112:32 pmRNSTotal Voting Rights
30th Sep 20217:00 amRNSTrading Update
17th Sep 20214:25 pmRNSTR-1: Notification of major holdings
13th Sep 20216:29 pmRNSTR-1: Notification of major holdings
13th Sep 20216:27 pmRNSTR-1: Notification of major holdings
13th Sep 202112:54 pmRNSTR-1: Notification of major holdings
13th Sep 202112:50 pmRNSTR-1: Notification of major holdings
1st Sep 20217:00 amRNSChange of Registered Office
10th Aug 20217:00 amRNSBoard Change
29th Jul 20216:07 pmRNSTR-1: Notification of major holdings
14th Jul 20217:00 amRNSTrading Update
14th May 20217:00 amEQSEdison Investment Research Limited: Numis Corporation (NUM): Very strong results, consistent strategy
7th May 20217:00 amRNSHalf Year Results
23rd Apr 20214:24 pmRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.